ADTX
Aditxt, Inc.
Key Financials
Revenue
$3195
↓ 97.6%
Net Income
$-43101451
↓ 6.8%
Operating Income
$-19570724
↑ 29.8%
Gross Profit
$268
↑ 100.1%
Total Liabilities
$12.6M
↓ 47.3%
Shareholders' Equity
$5.6M
↑ 1029.7%
EPS (Diluted)
$-1153.83
↑ 62.3%
Cash & Equivalents
$833031.00
↑ 757.9%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | ADTX |
| Company Name | Aditxt, Inc. |
| CIK | 1726711 |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 909-488-0844 |